192 related articles for article (PubMed ID: 10859222)
1. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
[TBL] [Abstract][Full Text] [Related]
2. Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats.
Nakade Y; Tsukamoto K; Iwa M; Pappas TN; Takahashi T
Auton Neurosci; 2007 Jan; 131(1-2):50-6. PubMed ID: 16938493
[TBL] [Abstract][Full Text] [Related]
3. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
Kolligs F; Fehmann HC; Göke R; Göke B
Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 is a physiological incretin in rat.
Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.
Tolessa T; Gutniak M; Holst JJ; Efendic S; Hellström PM
J Clin Invest; 1998 Aug; 102(4):764-74. PubMed ID: 9710445
[TBL] [Abstract][Full Text] [Related]
6. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.
Maillot C; Million M; Wei JY; Gauthier A; Taché Y
Gastroenterology; 2000 Dec; 119(6):1569-79. PubMed ID: 11113078
[TBL] [Abstract][Full Text] [Related]
7. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
8. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
Schirra J; Sturm K; Leicht P; Arnold R; Göke B; Katschinski M
J Clin Invest; 1998 Apr; 101(7):1421-30. PubMed ID: 9525985
[TBL] [Abstract][Full Text] [Related]
9. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.
Rinaman L
Am J Physiol; 1999 Nov; 277(5):R1537-40. PubMed ID: 10564228
[TBL] [Abstract][Full Text] [Related]
10. Evidence that glucagon stimulates insulin secretion through its own receptor in rats.
Kawai K; Yokota C; Ohashi S; Watanabe Y; Yamashita K
Diabetologia; 1995 Mar; 38(3):274-6. PubMed ID: 7758872
[TBL] [Abstract][Full Text] [Related]
11. Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat.
Edwards CM; Abbott CR; Sunter D; Kim M; Dakin CL; Murphy KG; Abusnana S; Taheri S; Rossi M; Bloom SR
Brain Res; 2000 Jun; 866(1-2):128-34. PubMed ID: 10825488
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus.
Oka JI; Goto N; Kameyama T
Neuroreport; 1999 Jun; 10(8):1643-6. PubMed ID: 10501550
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
14. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
15. Central, but not peripheral, glucagon-like peptide-1 inhibits crop emptying in chicks.
Tachibana T; Matsumoto M; Furuse M; Hasegawa S; Yoshizawa F; Sugahara K
Comp Biochem Physiol A Mol Integr Physiol; 2003 Apr; 134(4):777-81. PubMed ID: 12814786
[TBL] [Abstract][Full Text] [Related]
16. Central effects of glucagon-like peptide-1 on cold-restraint stress-induced gastric mucosal lesions.
Işbil Büyükcoşkun N; Güleç G; Cam Etöz B; Ozlük K
Turk J Gastroenterol; 2007 Sep; 18(3):150-6. PubMed ID: 17891687
[TBL] [Abstract][Full Text] [Related]
17. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.
Thiele TE; Seeley RJ; D'Alessio D; Eng J; Bernstein IL; Woods SC; van Dijk G
Brain Res; 1998 Aug; 801(1-2):164-70. PubMed ID: 9729361
[TBL] [Abstract][Full Text] [Related]
18. Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats.
Nakade Y; Tsukamoto K; Pappas TN; Takahashi T
Brain Res; 2006 Sep; 1111(1):117-21. PubMed ID: 16884700
[TBL] [Abstract][Full Text] [Related]
19. Effects of intracerebroventricular injection of glucagon like peptide-1 and its related peptides on serotonin metabolism and on levels of amino acids in the rat hypothalamus.
Owji AA; Khoshdel Z; Sanea F; Panjehshahin MR; Shojaee Fard M; Smith DM; Coppock HA; Ghatei MA; Bloom SR
Brain Res; 2002 Mar; 929(1):70-5. PubMed ID: 11852032
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
Bucinskaite V; Tolessa T; Pedersen J; Rydqvist B; Zerihun L; Holst JJ; Hellström PM
Neurogastroenterol Motil; 2009 Sep; 21(9):978-e78. PubMed ID: 19453518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
